Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma.
BAP1
GNA11
GNAQ
Q209L
Q209P
SF3B1
metastasis
metastatic uveal melanoma
survival
uveal melanoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
17 Nov 2021
17 Nov 2021
Historique:
received:
08
09
2021
revised:
11
11
2021
accepted:
13
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (
Identifiants
pubmed: 34830903
pii: cancers13225749
doi: 10.3390/cancers13225749
pmc: PMC8616238
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA253977
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA257505
Pays : United States
Références
Melanoma Res. 2005 Aug;15(4):297-304
pubmed: 16034309
J Vasc Interv Radiol. 2015 Apr;26(4):523-32.e2
pubmed: 25678394
Nature. 2009 Jan 29;457(7229):599-602
pubmed: 19078957
Mol Oncol. 2014 Dec;8(8):1508-20
pubmed: 24994677
Front Oncol. 2020 Oct 13;10:562074
pubmed: 33154942
Eye (Lond). 2017 Feb;31(2):241-257
pubmed: 27911450
Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1679-84
pubmed: 11431428
Semin Intervent Radiol. 2013 Mar;30(1):39-48
pubmed: 24436516
Br J Cancer. 2009 Sep 1;101(5):813-5
pubmed: 19654573
Clin Cancer Res. 2016 Mar 1;22(5):1234-42
pubmed: 26933176
N Engl J Med. 2013 May 23;368(21):1971-9
pubmed: 23656586
Mol Cancer Res. 2017 May;15(5):501-506
pubmed: 28223438
Cancers (Basel). 2019 Jun 19;11(6):
pubmed: 31248118
Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672
pubmed: 29738114
Br J Ophthalmol. 2015 Apr;99(4):437-9
pubmed: 25361747
Cancers (Basel). 2020 Aug 21;12(9):
pubmed: 32825562
N Engl J Med. 2010 Dec 2;363(23):2191-9
pubmed: 21083380
Pigment Cell Melanoma Res. 2016 Jan;29(1):60-7
pubmed: 26523470
Invest Ophthalmol Vis Sci. 2014 Jun 26;55(8):5160-7
pubmed: 24970262
Nat Commun. 2020 Apr 20;11(1):1894
pubmed: 32313009
Ocul Oncol Pathol. 2018 Apr;4(3):145-151
pubmed: 29765944
Cancer Cell. 2017 Aug 14;32(2):204-220.e15
pubmed: 28810145
Cancers (Basel). 2019 Aug 07;11(8):
pubmed: 31394807
Front Oncol. 2020 Nov 20;10:589849
pubmed: 33330070
Oncotarget. 2016 Jan 26;7(4):4624-31
pubmed: 26683228
Mod Pathol. 2014 Feb;27(2):175-83
pubmed: 23887304
JAMA Ophthalmol. 2021 Feb 1;139(2):174-181
pubmed: 33355644
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5230-4
pubmed: 18719078
Clin Cancer Res. 2005 May 15;11(10):3609-13
pubmed: 15897555
Nat Commun. 2018 Jan 9;9(1):116
pubmed: 29317634
JAMA Ophthalmol. 2018 Oct 1;136(10):1115-1120
pubmed: 30073324
J Biol Chem. 2018 Dec 21;293(51):19586-19599
pubmed: 30352874
Melanoma Res. 2014 Dec;24(6):525-34
pubmed: 25304237
BMC Cancer. 2014 Jun 02;14:392
pubmed: 24890689
Radiology. 2019 Oct;293(1):223-231
pubmed: 31453767
Br J Cancer. 2013 Jul 23;109(2):493-6
pubmed: 23778528
Ophthalmology. 2016 May;123(5):1118-28
pubmed: 26923342
Nat Genet. 2019 Jul;51(7):1123-1130
pubmed: 31253977
Nat Genet. 2016 Jun;48(6):675-80
pubmed: 27089179
PLoS Curr. 2013 Apr 09;5:
pubmed: 23591547
Br J Cancer. 2005 Nov 14;93(10):1191-6
pubmed: 16251874
Cancers (Basel). 2020 Jan 01;12(1):
pubmed: 31906411